Emilio Gil-Martín

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Free radical chemistryMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2023
Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells.

Rubén López-Cortés, Isabel Correa Pardo, Laura Muinelo-Romay

|Jun 28, 2023
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review.

Eva Ramos, Javier Egea, Francisco López-Muñoz

|Feb 25, 2023
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics.

Eva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos

|Aug 12, 2022
Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model.

Rubén López-Cortés, Laura Muinelo-Romay, Almudena Fernández-Briera

|Aug 06, 2021
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.

Eva Ramos, Francisco López-Muñoz, Emilio Gil-Martín

|Apr 30, 2021
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Alejandro Romero, Eva Ramos, Francisco López-Muñoz

Pageof 2

Frequent Collaborators

5 joint publications

Alejandro Romero

5 joint publications

Eva Ramos

5 joint publications

Francisco López-Muñoz

4 joint publications

Javier Egea